FDA INDICATION: Long-term treatment of adult patients with Gaucher disease Type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test. Package Insert
DISTRIBUTOR: Sanofi Genzyme
ROUTE OF ADMINISTRATION: Oral
DOSAGE AND ADMINISTRATION:
CYP2D6 EMs or IMs: 84 mg orally twice daily.
CYP2D6 PMs: 84 mg orally once daily.
HOW SUPPLIED: 84 mg hard gelatin capsules.
STORAGE REQUIREMENTS: Store at 68–77°F (20–25°C) with excursions permitted between 59–86°F (15–30°C).
OTHER WEBSITES: cerdelga.com, CareConnectPSS.com, GaucherCare.com